Sampre Nutritions has secured a significant manufacturing agreement with Tolaram Wellness Ltd., marking a major milestone for the Telangana-based company. The three-year contract, signed on August 16, 2025, is set to boost Sampre Nutritions' revenue by an estimated INR 10.00 crores annually, totaling INR 30.00 crores over the agreement's duration.

Deal Highlights

Agreement Terms

Under the terms of the agreement, Sampre Nutritions will exclusively manufacture and supply nutraceutical and food products for Tolaram Wellness. The products will be produced according to mutually agreed specifications and quality standards, enabling Tolaram Wellness to market and distribute them effectively.

Key aspects of the deal include:

• Pricing to be mutually agreed upon
• Payment terms: 50% advance, balance on dispatch
• Transportation costs to be borne by Tolaram Wellness

Strategic Implications

This partnership is expected to significantly contribute to Sampre Nutritions' revenue stream and support its operations in the nutraceutical and food product sectors. The agreement aligns with the company's focus on expanding its manufacturing capabilities and client base in the health food industry.

Corporate Governance

Sampre Nutritions has confirmed that this agreement does not constitute a related party transaction. The company disclosed that neither Tolaram Wellness nor any parties involved in the agreement are related to Sampre Nutritions' promoter group or group companies.

Market Impact

The announcement, made on August 28, 2025, underscores Sampre Nutritions' commitment to transparency and compliance with SEBI regulations. This strategic move is likely to be viewed positively by investors, potentially impacting the company's market performance in the coming quarters.

As the nutraceutical market continues to grow globally, this partnership positions Sampre Nutritions to capitalize on the increasing demand for health and wellness products, potentially opening doors for further expansion and collaborations in the future.

Sampre Nutritions Limited has announced a significant business development that is set to boost its nutraceutical and food product operations. The company has entered into a three-year manufacturing agreement with Rama Exports, a move expected to generate business worth INR 15.00 crores over the contract term.

Key Details of the Agreement

• Duration: 3 years
• Estimated Value: INR 15.00 crores over the contract term
• Scope: Manufacture, supply, quality assurance, and packaging of products
• Product Range: Nutraceutical and food products

Terms of the Agreement

Under the terms of the agreement, Rama Exports will purchase products manufactured by Sampre Nutritions at mutually agreed prices. The products will be produced according to Sampre Nutritions' specifications and will bear the company's brand names.

Disclosure and Compliance

In compliance with regulatory requirements, Sampre Nutritions has made the necessary disclosures under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that:

• Neither party holds shares in the other company
• The transaction does not involve related parties
• The agreement does not fall under related party transactions

Impact on Business

This manufacturing agreement is expected to contribute significantly to Sampre Nutritions' revenues, potentially strengthening its position in the nutraceutical and food product market. The deal underscores the company's manufacturing capabilities and its ability to secure substantial contracts in the industry.

Management Statement

Brahma Gurbani, Managing Director of Sampre Nutritions Limited, signed the disclosure document, indicating the company's commitment to transparency and regulatory compliance in its business dealings.

This strategic partnership between Sampre Nutritions and Rama Exports highlights the growing demand for nutraceutical and food products, and positions Sampre Nutritions to capitalize on this trend over the next three years.